How common is a mild isolated elevation of alkaline phosphatase in patients with non‑alcoholic fatty liver disease (NAFLD) when all other liver function tests are normal?

Isolated Mild Alkaline Phosphatase Elevation in NAFLD

A mild isolated elevation of alkaline phosphatase (ALP) in NAFLD patients with otherwise normal liver function tests is uncommon but well-recognized, occurring in a small subset of patients—predominantly older women—with typical elevations less than 2× the upper limit of normal (ULN). 1

How Common Is This Pattern?

The isolated ALP elevation pattern in NAFLD is relatively rare. According to consensus guidelines on NASH clinical trials, a small subset of NASH patients (predominantly women) may present with isolated elevation in ALP (typically <2× ULN) instead of the more typical aminotransferase elevations 1.

In a dedicated study examining this specific presentation, only 14 out of 135 patients (approximately 10%) with biopsy-proven NAFLD presented with isolated elevated ALP rather than the typical aminotransferase pattern 2. This represents a distinct minority of NAFLD cases.

Key Clinical Characteristics

When isolated ALP elevation does occur in NAFLD, specific demographic patterns emerge:

• Predominantly affects older females 2
• Within this group, those with steatohepatitis (rather than simple steatosis) tend to be older 2
• Importantly, 5 of 7 patients with steatohepatitis in the isolated ALP group had advanced liver disease at biopsy 2

Critical Clinical Implications

This presentation pattern should not be dismissed as benign. The guidelines are clear that elevation of ALP to ≥2× ULN is atypical of NASH, and other causes must be thoroughly investigated, including gallstone disease, hepatic tumor, pancreatic tumor, or drug-induced liver injury 1.

What This Means for Your Patient:

1. Most NAFLD patients have a hepatocellular pattern (elevated ALT/AST) rather than cholestatic (elevated ALP) 3, 1

2. If ALP is mildly elevated (<2× ULN) with normal other LFTs:

   • This can represent NAFLD, particularly in older women
   • The clinical significance remains poorly understood and requires further study 1
   • Consider that this subset may have more advanced disease despite the "mild" biochemical abnormality 2

3. If ALP is ≥2× ULN:

   • This is atypical for NAFLD and demands investigation for alternative diagnoses 1
   • Rule out biliary obstruction, infiltrative disease, or malignancy
   • Imaging (ultrasound initially) is essential 3

Important Caveats

Normal liver enzymes do not exclude significant NAFLD or advanced fibrosis. Serum ALT typically falls as fibrosis progresses, and patients with cirrhosis frequently have normal-range ALT 4. The same principle applies to isolated mild ALP elevations—they may mask significant underlying disease.

The typical NAFLD pattern is hepatocellular injury with ALT/AST elevation and AST:ALT ratio <1 (versus >2 in alcoholic liver disease) 3. Changes in liver tests due to underlying NASH are usually hepatocellular in nature 1.

Practical Approach

For a patient with mild isolated ALP elevation and suspected NAFLD:

• Confirm hepatic origin of ALP with GGT (if elevated, confirms hepatic source) 3
• Image the liver and biliary tree with ultrasound to exclude obstruction and assess for steatosis 3
• Consider the patient's demographics: older women are the typical profile for this presentation 2
• Maintain high suspicion for advanced disease despite "mild" biochemical abnormality, particularly if the patient is an older woman with metabolic risk factors 2
• Monitor closely as the natural history and optimal management of this subset remain incompletely defined 1